Current biomarkers of prostate cancer
Prostate cancer is one of the most common malignancies in men. Early detection of prostate cancer is largely determined by the widely used prostate specific antigen (PSA) blood test. However, as a diagnostic and prognostic test of prostate cancer, PSA has limited specificity, sensitivity and leads t...
Saved in:
Main Authors: | I. A. Aboian, E. N. Fedotova, A. N. Shevchenko, S. M. Pakus, A. Yu. Maximov, E. V. Filatova, I. A. Khomutenko, Е. F. Komarova, N. K. Guskova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
QUASAR, LLC
2021-12-01
|
Series: | Исследования и практика в медицине |
Subjects: | |
Online Access: | https://www.rpmj.ru/rpmj/article/view/710 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Value of Systematic and MRI‐Ultrasound Fusion Prostate Biopsy in Different Prostate Specific Antigen (PSA) Levels
by: Solmaz Ohadian Moghadam, et al.
Published: (2025-01-01) -
Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer
by: Yuxuan Chen, et al.
Published: (2025-01-01) -
Incidence of prostate adenocarcinoma in transurethral resection of the prostate patients
by: Yahia Ghazwani, et al.
Published: (2025-01-01) -
Urology pathways for the primary care physician
by: J John
Published: (2024-04-01) -
A Rare Metastasis of Prostate Cancer
by: İlkin Hamid-Zada, et al.
Published: (2024-07-01)